DBRC
IDXX icon

D.B. Root & Company’s Idexx Laboratories IDXX Stock Holding History

D.B. Root & Company’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-750
Closed -$416K – 183
2023
Q4 		$416K Sell
750
-328
-30% -$154K 0.15% 121
2023
Q3 		$471K Buy
1,078
+2
+0.2% +$997 0.18% 110
2023
Q2 		$540K Buy
1,076
+368
+52% +$176K 0.2% 108
2023
Q1 		$354K Hold
708
– – 0.14% 131
2022
Q4 		$289K Sell
708
-34
-5% -$13.2K 0.12% 137
2022
Q3 		$241K Buy
742
+14
+2% +$5.14K 0.11% 146
2022
Q2 		$255K Sell
728
-1
-0.1% -$408 0.11% 152
2022
Q1 		$398K Sell
729
-55
-7% -$28.9K 0.15% 141
2021
Q4 		$516K Sell
784
-14
-2% -$8.79K 0.19% 126
2021
Q3 		$496K Sell
798
-163
-17% -$110K 0.19% 130
2021
Q2 		$606K Sell
961
-20
-2% -$11K 0.23% 119
2021
Q1 		$480K Sell
981
-23
-2% -$11.5K 0.19% 142
2020
Q4 		$501K Buy
+1,004
New +$449K 0.2% 128

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

D.B. Root & Company's IDXX Position: Q1 2024 in Review

D.B. Root & Company sold out of Idexx Laboratories (IDXX) in Q1 2024, closing a stake of 750 shares — an estimated $416K sold.

D.B. Root & Company first reported a position in IDXX in Q4 2020 and held it in 13 quarters. The position peaked at $606K in Q2 2021. 1,149 funds tracked by Wall St. Rank hold IDXX as of Q1 2024.

  • D.B. Root & Company reported no remaining Idexx Laboratories position as of Q1 2024 after selling out during the quarter.
  • D.B. Root & Company sold 750 Idexx Laboratories shares in Q1 2024, an estimated $416K.
  • D.B. Root & Company first reported a position in Idexx Laboratories in Q4 2020 and held it in 13 quarters.
  • D.B. Root & Company's Idexx Laboratories position peaked at $606K in Q2 2021.
  • 1,149 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2024.

Based on D.B. Root & Company's 13F filing for Q1 2024, filed 17 Apr 2024.